HMPV update: States advised to strengthen awareness among masses regarding preventive measures
Data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country
Data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country
Successfully transformed the organization from a two-country operation focused on development and manufacturing to a fully integrated company with a strong commercial engine bringing us closer to patients in over 120 countries
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
Smeeta Bhatkal, Santosh Desai and Akshay Kumar join as Independent Directors; Shaina NC as Non-Executive Director
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
SPARC to receive 55% equity in Tiller Therapeutics
Subscribe To Our Newsletter & Stay Updated